The exploration of novel cell lines to be used in CAR-based therapies has opened many possibilities for future ‘CGT 2.0’ treatments, both allogeneic and autologous. Join us at our new CAR & T Cell Therapies track within BPI West to learn more about these emerging CGT 2.0 cell lines, and the opportunities they hold.
27 February-02 March 2023